Waldenström's Macroglobulinemia Treatment

Treating Waldenstrom Macroglobulinemia - American Cancer Society

The 2 main ways to treat WM are chemotherapy and different types of biological therapy (immunotherapy). One or both of these types of treatments might be used.

Waldenstrom macroglobulinemia - Diagnosis and treatment

Bone marrow transplant. In select instances, a bone marrow transplant, also known as a stem cell transplant, may be a treatment for Waldenstrom ...

Waldenström's Macroglobulinemia Treatment

Your treatment for Waldenström's macroglobulinemia will be customized to your particular needs. One or more of the following therapies may be recommended.

Waldenström Macroglobulinemia: Treatment Options

Although Waldenström macroglobulinemia (WM) is an incurable disease, it is treatable, and many patients have a long-term response to treatment.

How I treat Waldenström macroglobulinemia | Blood

Rituximab with oral or intravenous cyclophosphamide and dexamethasone (DRC, for 6 cycles) remains a commonly used regimen with low short- and ...

How We Treat Waldenström's Macroglobulinemia

Your care will combine the finest treatments currently available for Waldenström's with innovative new therapies based on research discovered in our ...

Waldenstrom Macroglobulinemia Treatment & Management

The purine nucleoside analogues fludarabine and cladribine have demonstrated activity against Waldenström macroglobulinemia. They are effective ...

When to Treat People with Waldenstrom Macroglobulinemia

Waldenstrom macroglobulinemia (WM) is generally not considered to be curable, but it is treatable. Many different medicines can help keep WM ...

Treatment for Waldenström macroglobulinaemia (WM)

The type of treatment you'll need will depend on how far the Waldenström macroglobulinaemia (WM) has developed.

Treatment for Waldenström Macroglobulinemia

Chemotherapy. Chemotherapy is one of the main treatments for WM. Your physicians may recommend chemo alone or in combination with targeted ...

Treatment Regimens and Considerations

The medications used to treat Waldenstrom macroglobulinemia can be given is a variety of combination and schedules. Most of the recommended regimens include ...

Efficacy and safety of front-line treatment regimens for Waldenstrom ...

Rituximab-based chemo-immunotherapy is currently the standard first-line treatment for Waldenstrom macroglobulinaemia (WM), while ibrutinib has emerged as an ...

Waldenström's macroglobulinemia front line treatment - PMC

Rituximab in combination with cyclophosphamide and dexamethasone or bendamustine are highly effective regimens with manageable toxicity and are considered ...

Waldenström's Macroglobulinemia - Dana-Farber Cancer Institute

Waldenström's macroglobulinemia (WM) is an uncommon blood cell cancer that originates from malignant B-cells. It is a slow-growing type of non-Hodgkin lymphoma.

Treatment and prognosis of Waldenström macroglobulinemia

Outline · Choice of initial therapy · Bendamustine plus rituximab · Bruton tyrosine kinase inhibitors · - Zanubrutinib · - Ibrutinib · - ...

About Waldenström's macroglobulinaemia (WM)

Treatment for Waldenström's macroglobulinaemia · Chemotherapy. Chemotherapy uses anti-cancer (cytotoxic) drugs to destroy cancer cells. · Targeted therapy.

Understanding the Treatment of Waldenström's Macroglobulinemia

Treatment—and there is no established standard—is mainly focused on controlling symptoms and preventing organ damage.

Current and emerging treatments for Waldenström's ... - YouTube

... treatments for Waldenström's macroglobulinemia (WM). Patients with WM are either treated with fixed-duration chemoimmunotherapy or with ...

Treatment recommendations for patients with Waldenström ...

Waldenström macroglobulinemia (WM) is a distinct B-cell lymphoproliferative disorder for which clearly defined criteria for the diagnosis, ...

Primary Treatment of Waldenström Macroglobulinemia With ...

Our large, multicenter trial showed that the non–stem-cell toxic DRC regimen is an active, well-tolerated treatment for symptomatic patients with WM.